Instructions For Authors

Getting Started

Authors must submit their manuscripts through the online submission platform available at https://editorialassist.com/jish. Articles submitted as hard copies are not accepted.

All first-time users need to register themselves. Registration is free. Once registered, authors can use their username and password to submit and keep track of their articles. In case of any problems, the author can contact the Technical Assistance team at: technical.team@scientificscholar.com.

Categories of Manuscripts

The Journal of Integrated Standardized Homoeopathy publishes manuscripts in the following categories

  • Original Articles (These include Randomized Controlled Trials, Intervention Studies, Pilot Research Projects, Observational studies, Research studies on Homoeopathic education, Community research, case-control series).
  • Review Article
  • Case Series
  • Case Reports 
  • Proceedings of scientific conferences and research meets
  • Book Reviews
  • Letter to the Editor

General Information

The Journal of Integrated Standardized Homoeopathy (JISH) is a Quarterly e-journal. The main aim of this journal is to promote Evidence-based Scientific Homoeopathy by publishing original research papers in Homoeopathy, well documented evidence-based case reports and papers demonstrating the application of Homoeopathy in different areas of Clinical practice, Homoeopathic Medical Education, Community care, Hospital-based Homoeopathic Practice, Drug proving, clinical research, extramural research, and collaborative research in Homoeopathy.

Author Responsibility

The journal accepts only original works that have not been published elsewhere. All authors must confirm that neither the manuscript nor any part of it was written or published or is under consideration for publication elsewhere. Publication of the content as an abstract during the proceedings of meetings is not considered prior publication; such articles can be submitted for publication. At the time of submission, authors should disclose details, if the study described in the manuscript had been previously presented in a meeting or published as an abstract. The details have to be mentioned in the Acknowledgments section. Any use of previously published material protected by copyright laws must be clearly acknowledged in the manuscript. Publishing of material on a website may be considered prior publication and should be mentioned at the time of submission. Authors should disclose details of related papers, even those authored in a different language.

Authorship credit should be based only on substantial contributions to one or more of the four components mentioned below:

  1. Concept and design of the study, acquisition of data, or analysis and interpretation of data;
  2. Drafting the article or revising it critically for important intellectual content;
  3. Final approval of the version to be published; and
  4. Aptitude to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Each contributor should have participated sufficiently in the work to take public responsibility for appropriate content of the manuscript. The order of naming the contributors should be based on the relative contribution of the individual included for authorship credit toward the study itself and the writing of the manuscript. Once the article has been submitted, the order cannot be changed without written consent from all the contributors. The journal permits a maximum number of eight authors for all categories of manuscripts, except for Case Reports and Case Series, where a maximum of four authors are permissible.

The authors need to identify one author who will correspond with the Journal office in all matters related to the manuscript called the Corresponding Author. The content of the final manuscript including changes suggested by the Editor or reviewer of the manuscript is the responsibility of the corresponding author.

Ethics

Studies conducted must adhere to and be in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. According to (Federal Research Misconduct Policy) scientific misconduct includes:

  • Data falsification: Fabrication, deceptive and selective reporting of findings, suppression of data and/or distortion of data
  • Plagiarism: Use without permission the language, ideas, or thoughts of another and representation of them as one’s own original work

Direct copying of sentences, whether from their previously published paper or from someone else’s paper, is considered as plagiarism. Authors need to check that they have not inadvertently ‘cut and paste’ verbatim from published works. 

According to the World Association of Medical Editors

Plagiarism is the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).

Self-plagiarism refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional. The journal requires authors to disclose information and cite references about reused content from previously published work of their own or of others.

Incorrect authorship: Excluding authors, wrongly presenting the same material as original in more than one publication, the inclusion of authors who have not made a definite contribution to the work published; or submission of articles without the concurrence of all authors.

Misappropriation of others’ ideas: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.

Violation of generally accepted research practices: Improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.

Material failure to comply with legislative and regulatory requirements affecting research: Violations of regulations and laws involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials.

Any form of unethical behaviour is strictly discouraged and will result in the submitting author and his group from being banned from submitting material to the journal for a time frame depending on the severity of malpractice.

Digital Image Editing Ethics

No particular feature within an image may be introduced, moved, enhanced, obscured, or removed. Adjustments of brightness, contrast, or colour balance are allowed if they are applied to the whole image and do not obscure or eliminate any information present in the original image. Adjustments such as changes to settings must be disclosed in the figure legend.

Contribution Details

Authors should provide a description of contributions made by each of them toward the manuscript. The description should be divided into the following categories, as deemed applicable: concept, design, the definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One or more authors should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as ‘guarantor’ or ‘guarantors’.

Conflicts of Interest/Competing Interests

All authors must disclose any and all conflicts of interest they may have with the publication of the manuscript or any institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose any conflict of interest with products that compete with those mentioned in their manuscript.

Institutional Review Board Approval and Informed Consent

All prospective and retrospective human studies must have appropriate institutional review board approval, and signed informed consent from all human participants is required. All animal studies must have appropriate institutional review board or animal care committee approval.

Compliance with these rules must be stated in the text, including waiver of consent by the board, if applicable. Manuscripts that do not comply with these rules will not be accepted for publication.

Patient consent and or Ethical approval statements along with Protocol number and date must be included in all research articles.

Protection of Patients’ Right to Privacy

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent/guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, CT scans, photographs, sonograms, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort the scientific meaning and editors should so note.

The Editorial Process

Manuscripts are subjected to an unbiased blinded peer review process. Decisions on the manuscripts are based solely on the peer review process and the Editor’s discretion and the decision is final.

Manuscripts that are found suitable for publication in the Journal of Integrated Standardized Homoeopathy are sent for blind review. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. The comments and suggestions (acceptance/rejection/amendments to the manuscript) received from reviewers are conveyed to the author. The author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copy-edited for grammar, punctuation, print style, and format. Galley proofs are sent to the author. The author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to the final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online immediately on final acceptance.

Manuscripts that do not conform to the Author Guidelines or exceed the maximum limits set for Articles may be returned to the author without review. The authors can resubmit after complying with the requirements.

Preparation of the Manuscript

The manuscript should be double-spaced, with a 2.5 cm margin, 12-point Times New Roman font and justified. The pages of the manuscript should be numbered on the bottom right corner.

Language and Writing Style

The manuscript should be written in English (United Kingdom). The author should write the full term for each abbreviation at its first use in the title, abstract, keywords, and text separately unless the abbreviation is a standard unit of measure. Use of acronyms and abbreviations must be kept to a minimum. When used, they are defined at first mention, followed by the acronym or abbreviation in parentheses. If a brand name is cited, supply the manufacturer’s name and address (city, state, and country). Manuscripts will be altered to meet the style guidelines of the Journal of Integrated Standardized Homoeopathy. Authors are requested to check the manuscript for spelling, grammar, and punctuation errors before submission. Headings and titles must be in sentence case and not in Capitals.

Organization of Sections in an Article

Cover Page

The cover page includes (a) complete manuscript title; (b) List all authors’ full names, highest academic degrees, professional titles, affiliations, and locations of affiliations; (c) name and address of the corresponding author, including, telephone number, and e-mail address and (d) sources of support that require acknowledgment, and a short title of no more than 45 characters (including spaces) for use as a running title.

Abstract

An abstract is required for all categories of manuscripts.

For an Original Research article, the abstract should be divided into four sections: Objective, Methods, Results, and Conclusions. It should not exceed 300 words.

No abstract should contain any figures, tables, or references, trade names, or manufacturers names.

Keywords

Provide up to five keywords at the end of the abstract for all types of articles except for Letters to the Editor and Replies.

Introduction

All articles need an Introduction that describes the objective of the investigation of not more than 500 words. The author should clearly state the specific goal or purpose of the article, and indicate why it is worthy of attention. In the Introduction, describe the hypothesis to be tested, the dilemma to be resolved, or the deficiency to be remedied.

Materials and Methods or Subject Profile

The research plan, the materials (or subjects), and the methods used should be described. An explanation on how the disease was confirmed and the controls used must be included, as well as the details of the data obtained and how it was analyzed. Methods must include the following aspects:

When a surgical device is mentioned in the manuscript for the first time, its manufactures complete detail should be mentioned such as the BRANDED name of the device/medication followed by name of manufacturer, city, and state. For example: IVC filter (C.R. Bard, Inc. Murray Hill, New Jersey, USA). Please mention the name of the Ultrasound machine, its manufacturer, and country of origin. In addition, please mention the type of the transducer and its frequency used for the study. This should be mentioned in the methods or the section where you describe how the ultrasound was performed. For example: GE, Logiq E9, Milwaukee, USA

Ethics: When reporting studies on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). For prospective studies involving human participants, authors are expected to mention about approval of (regional/national/institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals were followed.

Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors. Animal experimental procedures should be as humane as possible and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the (CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively). The journal will not consider any manuscript that is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all original research manuscripts under the ‘Materials and Methods’ section.

Patient consent: Patient anonymity must be maintained in all submissions. If there is any possibility that the patient can be identified in a figure, written consent must be obtained from the patient or parent/guardian by the author, and a line stating that this has been received included in the article.

Study Design

Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Reports of randomized clinical trials should present information on all major study elements, including the protocol number and date, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).

Statistics

Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Result section, specify the statistical methods used to analyse them. Avoid non-technical uses of technical terms in statistics, such as ‘random’ (which implies a randomizing device), ‘normal’, ‘significant’, ‘correlations’, and ‘sample’. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. For all P values include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

Results

All results should be in a clear, logical sequence and should adhere to the specific objective of the paper. Data presented in tables should not be duplicated in the text. Important trends and points observed in the study will need to be described. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyse them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data according to variables such as age and sex should be included.

Discussion

The article submitted should explain clearly the outcome of the research considering the goals and results obtained. Any limitations on the materials or subjects and methods must be included. How the results differ from those obtained by previous investigators need to be presented with adequate comparisons and explanations. Include key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence should be described. Include what this study adds to the available evidence, effects on patient care and health policy, etc.

Do not repeat the data or other material mentioned in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed.

References

References are to be numbered sequentially in the order in which they appear in the manuscript. Reference numbers are typed as superscripts, enclosed by square brackets, after the punctuation mark at the end of the line.

Example: …… with no evidence of intratubular testicular neoplasia.[1]

Unpublished data or articles submitted for publication are not to be cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J, unpublished data). Papers presented at meetings are not cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J et al., presented at the 2009 annual meeting of the Society).

References follow the ICMJE guidelines. The author’s surname is followed by the author’s initials in capitals without spaces or full stops. All references show page numbers in the format (121-26). Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list from here.

Sample references are given below:

Articles in Journals
1. Olson MC, Posniak HV, Fisher SG, Flisak ME, Salomon CG, Flanigan RC, et al. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations. Am J Roentgenol 1994;163:1407–1411.

List the first six contributors followed by et al in all references.

Issue with supplement
Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996;23(1, Suppl 2):89-97.

Volume with supplement
Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.

Books and Other Monographs

Personal Author(s):

Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

Editor(s), compiler(s) as author:

Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

Chapter in A Book
Turgut AT, Dogra VS. Prostate carcinoma: Evaluation using transrectal sonography. In: Hayat MA, ed. Methods of cancer diagnosis, therapy and prognosis. 1st ed. New York, NA: Elsevier; 2008. p. 499-520.

Electronic Sources as Reference

Journal article on the Internet
http://www.apastyle.org/learn/quick-guide-on-references.aspx

Monograph on the Internet
Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9].
Available from: http://www.nap.edu/books/0309074029/html.

Homepage/Web site
Available at http://www.apastyle.org/learn/quick-guide-on-references.aspx.

Part of a homepage/Web site
Available at http://www.apastyle.org/learn/quick-guide-on-references.aspx.

Tables

Tables must be significant and provide a good summary of the study. Tables should be self-explanatory and not duplicate the data given in the text or figures. Each table must have a descriptive title, and each column a heading. Tables must contain a minimum of four lines and two columns of data and not exceed 10 columns and 25 rows. Tables are numbered in the order in which they are cited in the text. Abbreviations used in the tables are defined below each table. All arithmetic calculations (percentages, totals, differences) must be double-checked for accuracy, and data must agree with the data given in the text.

Graphs

Graphs need to be exported as JPEG or TIF images and submitted as figures. Graphs and line drawings need to be a minimum of 1000 dpi. Graphs should include clearly labeled error bars described in the figure legend. Authors must state whether a number that follows the ± sign is a standard error (SEM) or a standard deviation (SD). The number of independent data points (N) represented in a graph must be indicated in the legend. Numerical axes on graphs should go to 0, except for log axes.

Figure/Image Legends

All figure parts relating to one image should have the same figure number. The style for figure legends is given here:
Figure 1: Age and sex of the patient followed by presenting symptoms and subsequent diagnosis. Imaging modality used, organ/section imaged, view, and abnormality seen in the image. Add arrows pointing to the abnormality seen in the image.
Example: Figure 1: 42-year-old woman with Behçet disease who presented with dyspnoea. (a) Contrast-enhanced CT image shows the increased diameter of both middle and lower lobe pulmonary arteries (arrows) on the right; the aneurysms are partially thrombosed. (b) CT image with lung window shows well-defined lung parenchymal nodules (arrow) corresponding to the aneurysms.

Written permission to reprint in print and electronic media, including online use, must be obtained for all previously published illustrations, and an appropriate credit line to be given in the legends.

Figures/Images

All images should be uploaded in JPEG, or TIF, format. The file size should be within 12 MB in size. Figures should be numbered consecutively according to the order in which they have been first cited in the text. Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column. Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen. Titles and detailed explanations belong in the legends for figures not on the figure/image themselves. The photographs and figures should be trimmed to remove all the unwanted areas and the patient’s name and medical record number. If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph and eyes must be covered. If a figure has been published elsewhere, the original source must be acknowledged and written permission from the copyright holder submitted to reproduce the material. A credit line should appear in the legend for such figures. Electronic manipulation of images that materially alters the medical information must be identified and the nature of the alterations described. Symbols used must be uniform in size and style and large enough to withstand reduction. Line drawings and graphs should be in black on a white background, using the same size type as the text. 0.5 mm hairline rules must be avoided. Authors’ names and affiliations must not appear anywhere on the images.

Image Size

Black & white images: JPEG, or TIF format, Grayscale mode, and 300 DPI resolution. The height and width of an image should be at least 6 x 5 inches.

Colour images: 300 DPI resolution, no layered files, no alpha channels. Color profile if used: CMYK (No Indexed Colour, Lab, or RGB profiles)

Line art: 1200 DPI resolution, Grayscale or Jpeg format. No layered files, no alpha channels. Color profile if used: CMYK (No Indexed Colour, Lab, or RGB profiles) The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.

Video Clips

The journal encourages authors to submit video clips, cine clips, or real-time images (preferably in ‘mp4’). The maximum size of each multimedia file should not exceed 30 MB. In addition to the video content, authors must provide a still image from each video file. Supply TIFF or JPEG files.

Submission of the Manuscript

Online Manuscript Submission

All manuscripts must be submitted online at the Journal of Integrated Standardized Homoeopathy. You will see step-by-step instructions when you are submitting your manuscript. You will need to submit the following documents as separate files.

  1. Covering Letter:
    The covering letter must be addressed by all the author(s) to the editor; it must contain the title and the category for which it is submitted. It must also contain a declaration that the work is original and has not been published or submitted for publication elsewhere. It should also contain the official designation of the author(s), along with the Mobile number, email, webpage (if any) and should preferably include the authors ORCiD ID
  2. Cover Page:
    The cover page includes (a) complete manuscript title; (b) List all authors’ full names, highest academic degrees, professional titles, affiliations, and locations of affiliations; (c) name and address of the corresponding author, including, telephone number, and e-mail address and (d) sources of support that require acknowledgment, and a short title of no more than 45 characters (including spaces) for use as a running title.
  3. Manuscript:
    This document should include the title, abstract, keywords, manuscript body, and references. This must be in the document format. Acknowledgment Section should be included at the end of the main manuscript. The author’s name and institution should not be reflected in the main manuscript. Acknowledgment should not contain the name of the city or the institution.
  4. Figures:
    Figures must be submitted in .tiff or jpeg format. Colour images should be of good quality. Each image should be less than 1 MB in size. The size of the image can be reduced by decreasing the actual height and width of the images (1240 x 800 pixels or 5-6 inches).
    Figure legends are uploaded as a document format.
  5. Graphs:
    Do not embed them in the main manuscript. They should be uploaded separately at the time of uploading the figures in the “jpeg” or “tiff” format.
  6. Tables:
    Tables should be included in the main manuscript file after the references.
  7. Copyright and disclosure forms are available for download from the author’s panel and should be uploaded as PDF files.
  8. Instruction on supplemental digital multimedia/video content: In addition to the video content, authors must provide a still image from each video file. Supply TIFF or JPEG files. These are also uploaded at the time of figure upload.

Specific Details for Each Manuscript Type

Case Reports
Such reports should contain usually less than 2,000 words, excluding abstract of not more than 200 words. While writing case reports, the CARE guidelines, modified for Homoeopathic cases, as reproduced below should be followed. The word count is exclusive of the reference list.

Table 1

The Modified for Homoeopathy CARE guidelines checklist
The Narrative: A case report tells a story in a narrative format that includes the presenting concerns, clinical findings, diagnoses, interventions, outcomes (including adverse events), and follow-up. The narrative should include a discussion of the rationale for any conclusions and any take-away messages.

Item nameItem no.Brief description
Title1The words “case report” (or “case study”) should appear in the title along with the phenomenon of greatest interest (e.g., symptom, diagnosis, test, intervention)
Keywords2The key elements of this case in 2-5 words
Abstract3a) Introduction—What does this case add?
  b) Case Presentation:
  – The main symptoms of the patient
  – The main clinical findings
  – The main diagnoses and interventions
  – The main outcomes
  c) Conclusion—What were the main take-away lessons from this case?
Introduction4Brief background summary of this case referencing the relevant medical literature
Patient Information5a) Demographic information (e.g., age, sex, ethnicity, occupation)
  b) Main symptoms of the patient
  c) Medical, family, and psychosocial history—including diet, lifestyle, and genetic information whenever possible, and details about relevant co-morbidities including past interventions and their outcomes
  d) The physical generals and particulars
Clinical Findings6Describe the relevant physical examination (PE) findings
Timeline7Depict important dates and times in this case (table or figure)
Diagnostic Assessment8a) Diagnostic methods (e.g., PE, laboratory testing, imaging, questionnaires)
  b) Diagnostic challenges (e.g., financial, language/cultural)
  c) Diagnostic reasoning including other diagnoses considered
  d) Prognostic characteristics (e.g., staging) where applicable
Analysis and Synthesis9Present the totality after indicating adequate classification and evaluation of the symptoms
Totality and Processing10Erect the totality in the appropriate way and indicate the processing through repertorial/non-repertorial methods
Susceptibility assessment and Planning and Programming11Where indicated, a full analysis of the assessment of Susceptibility and its impact on Planning and Programming may be presented
Therapeutic Intervention12a) Types of intervention (e.g., pharmacologic, surgical, preventive, self-care)
  – Administration of intervention (e.g., dosage, posology, duration)
  – Changes in the intervention (with rationale)
Follow-up and Outcomes13a) Summarize the clinical course of all follow-up visits including
  – Clinician and patient-assessed outcomes
  – Important follow-up test results (positive or negative)
Discussion14a) The strengths and limitations of the management of this case
  b) The relevant medical literature
  c) The rationale for conclusions (including assessments of cause and effect)
  d) The main take-away lessons of this case report
Patient Perspective15The patient should share his or her perspective or experience whenever possible

Case Series

Such article should be written generally in less than 3,000 words, but should include preferably a structured abstract of not more than 250 words. The case series taken by the author should be integrated as a part of the review article. The word count is exclusive of the reference list.

Original Articles

These include randomized controlled trials, intervention studies, Pilot Research Projects, Observational studies, Research studies on Homoeopathic education, case-control series.

These should be written generally in less than 3,000 words excluding a structured abstract of not more than 300 words. The article should usually be organized in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list). It should contain between 3 and 5 keywords. These articles should enhance the existing knowledge on teaching methodology; curriculum development; lesson plan; existing lacuna(e) in the education domain and how to overcome them, etc. The word count is exclusive of the reference list.

It should contain a structured abstract of not more than 300 words. A structured abstract should cover (in the following order): the purpose of the article, its materials and methods (the experimental system and procedures used), the results and conclusions.

Articles on qualitative and quantitative research; prospective /retrospective studies are welcome. All articles must clarify how the findings of the study will advance the existing knowledge on the subject concerned. The research studies may be reported in the format mentioned in Table 2. The word count is exclusive of the reference list.

Table 2

STROBE statement/ checklist of items that should be included in reports of observational studies

Item nameItem NoRecommendation
Title and abstract
 1(a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done and what was found
Introduction
Background/rationale2Explain the scientific background and rationale for the investigation being reported
Objectives3State specific objectives, including any pre-specified hypotheses
Methods
Study design4Present key elements of study design early in the paper
Setting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection
Participants6

(a)   Cohort study: Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up

(b)   Case-control study: Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls Cross sectional study? Give the eligibility criteria, and the sources and methods of selection of participants

(c)    Cohort study: For matched studies, give matching criteria and number of exposed and unexposed

(d)   Case-control study: For matched studies, give matching criteria and the number of controls per case

Variables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable
Data sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group
Bias9Describe any efforts to address potential sources of bias
Study size10Explain how the study size was arrived at
Quantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why
Statistical methods12Describe all statistical methods, including those used to control for confounding
Describe any methods used to examine subgroups and interactions
Explain how missing data were addressed

(a)   Cohort study: If applicable, explain how loss to follow-up was addressed

(b)   Case-control study: If applicable, explain how matching of cases and controls was addressed

(c)    Cross sectional study: If applicable, describe analytical methods taking account of sampling strategy

Describe any sensitivity analyses
Results
Participants13*Report numbers of individuals at each stage of study: e.g. numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed
Give reasons for non-participation at each stage
Consider use of a flow diagram
Descriptive data14*Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders
Indicate number of participants with missing data for each variable of interest
Cohort study: Summarise follow-up time (e.g. average and total amount)
Outcome data15*

(a)   Cohort study: Report numbers of outcome events or summary measures over time

(b)   Case-control study: Report numbers in each exposure category, or summary measures of exposure

(c)    Cross sectional study: Report numbers of outcome events or summary measures

Main results16Report the numbers of individuals at each stage of the study, e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed
Give reasons for non-participation at each stage
Consider use of a flow diagram
Other analyses17Report other analyses done: e.g., analyses of subgroups and interactions, and sensitivity analyses
Discussion
Key results18Summarise key results with reference to study objectives
Limitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias
Interpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability21Discuss the generalisability (external validity) of the study results
Other information
Funding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based

*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.

Review Articles:

The prescribed word count is up to 3000 words excluding tables, references and abstract. The manuscript may have about 30 references. The manuscript should have an unstructured Abstract (300 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review article should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.

JISH expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of the article and should be sent as a letter to editor, as and when major development occurs in the field.

Proceedings of scientific conferences and research meets

Up to 1000 words. It should include the theme, conduct, and take-home lessons clearly enunciated.

Book Review:

These require a pre-submission inquiry; please contact the editor if you are interested in submitting an article for these.

Letter to the Editor

It may contain up to 400 words. It may send very brief vignettes or offer comments to articles published in the preceding issue/s.
Note:

  1. While writing references for the above categories of articles, the Vancouver style should be followed.
  2. For the References – the use of reference management software (such as End Note) is not required.

Publication/Processing Fee

Article Processing Charge

The Journal of Integrated Standardized Homoeopathy does not charge the authors for the submission, processing and/or publications of manuscripts.

Authors Retain Copyright

Authors retain their copyright for all articles when they publish in the Journal of Integrated Standardized Homoeopathy. Authors grant Scientific Scholar an exclusive license to publish the article and the article is made available under the terms of a Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0).

Copyright Transfer Agreement

Copyright forms can be downloaded from the submission system.

Authors Retain Copyright

Authors retain their copyright for all articles when they publish in  the Journal of Integrated Standardized Homoeopathy. Authors grant Scientific Scholar an exclusive license to publish the article and the article is made available under the terms of a Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0).

Open Access Publication and Creative Commons Licensing

This is an Open Access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical term.

Compliance with Funder-Mandated Open Access Policies

An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License is able to meet that requirement through the available open access license for approved funders.

For any Questions or Difficulties please contact us technical.team@scientificscholar.co